abstract |
There is provided an HCV replication inhibitor of formula (I), a stereochemically isomer thereof, and a salt, hydrate, solvate thereof: In this formula, R 1 , R 2 , R 4 , R 5 , R 6 and R 7 have the meanings as defined in the claims. The invention also relates to a process for the preparation of said compounds, pharmaceutical compositions comprising said compounds and their use as HCV therapeutics. |